Table 2 Comparison of patients carrying only CPE versus patients carrying only CPNF

Age (years)

68 (48–74)

65 (54–72)

0.99 (0.97–1.02)

Female sex

34 (42.5)

11 (39.3)

1.14 (0.47–2.75)

Localization before hospitalization

0.37 (0.23–0.60)

0.68 (0.36–1.30)

Home

Nursing home

Other acute care facility

61 (76.3)

2 (2.5)

17 (21.3)

9 (32.1)

1 (3.6)

18 (64.3)

Discipline/ward

0.82 (0.54–1.23)

Surgery

Medicine

Isolation ward

Gynaecology

Urology

31 (38.8)

40 (50.0)

8 (10.0)

1 (1.3)

0

13 (46.4)

12 (42.9)

0

0

3 (10.7)

History of hospitalization^a

Stay in ICU

69 (86.3)

9 (11.3)

24 (85.7)

6 (21.4)

1.05 (0.30–3.59)

0.45 (0.14–1.43)

History of colonization with CPB^a

History of colonization with ESBL-PE^a

27 (33.8)

28 (35.0)

2 (7.1)

4 (14.3)

6.62 (1.46–30.01)

3.23 (1.02–10.24)

10.43 (1.59–68.56)

2.65 (0.54–12.99)

Travel history^a

Hospitalization abroad^a

35 (43.8)

31 (38.8)

20 (71.4)

18 (90.0)

0.31 (0.12–0.79)

0.86 (0.14–5.18)

0.68 (0.19–2.41)

CCI

2 (1–4)

1 (0–2)

1.84 (1.31–2.60)

1.58 (1.04–2.40)

Antibiotic therapy prior to detection of CPB^b

53 (66.3)

24 (85.7)

0.33 (0.10–1.04)

Immunosuppressing therapy^a

20 (25.0)

3 (10.7)

2.78 (0.76–10.19)

PPI^a

43 (53.8)

12 (42.9)

1.55 (0.65–3.69)

Chronic wounds

9 (11.3)

7 (25.0)

0.38 (0.13–1.14)

Recent surgery^a

36 (45.0)

15 (53.6)

0.71 (0.30–1.68)

Urinary catheterization^c

20 (25.0)

22 (78.6)

0.09 (0.03–0.26)

0.10 (0.03–0.35)

Vascular hardware^d

7 (8.8)

5 (17.9)

0.44 (0.13–1.52)

Outcome

Infection due to CPB

17 (21.3)

8 (28.6)

0.67 (0.25–1.80)

Length of hospital stay (days)

15 (9–32)

22 (9–41)

0.99 (0.97–1.00)

Death

4 (5.1)

9 (32.1)

0.11 (0.03–0.41)